PA
NVO

PSI Advisors’s Novo Nordisk NVO Stock Holding History

PSI Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-225
Closed -$15.6K – 484
2025
Q1 		$15.6K Hold
225
– – 0.01% 396
2024
Q4 		$19.4K Sell
225
-28
-11% -$3.03K 0.01% 425
2024
Q3 		$30.1K Hold
253
– – 0.01% 346
2024
Q2 		$36.1K Hold
253
– – 0.01% 305
2024
Q1 		$32.5K Sell
253
-54
-18% -$6.43K 0.01% 323
2023
Q4 		$31.8K Buy
307
+107
+54% +$10.6K 0.01% 329
2023
Q3 		$18.2K Hold
200
– – 0.01% 407
2023
Q2 		$16.2K Buy
+200
New +$16.3K 0.01% 420

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

PSI Advisors's NVO Position: Q2 2025 in Review

PSI Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 225 shares — an estimated $15.6K sold.

PSI Advisors first reported a position in NVO in Q2 2023 and held it in 8 quarters. The position peaked at $36.1K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • PSI Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • PSI Advisors sold 225 Novo Nordisk shares in Q2 2025, an estimated $15.6K.
  • PSI Advisors first reported a position in Novo Nordisk in Q2 2023 and held it in 8 quarters.
  • PSI Advisors's Novo Nordisk position peaked at $36.1K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.